Showing results (801-810 of 861) with videos related to

Sort By:
Pageof 87
Nature Materials|June 6, 2018
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptanceDevon M Headen, Kyle B Woodward, María M Coronel, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Obstructive Sleep Apnea is a Risk Factor for Incident COVID-19 InfectionStuart F Quan, Matthew D Weaver, Mark É Czeisler, et al.
Prehospital Emergency Care|June 22, 2023
Effect of Short versus Long Duration Naps on Blood Pressure during Simulated Night Shift Work: A Randomized Crossover TrialP Daniel Patterson, Tiffany S Okerman, David G L Roach, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
Sleep Medicine Reviews|June 11, 2021
Does the evidence support brief (≤30-mins), moderate (31-60-mins), or long duration naps (61+ mins) on the night shift? A systematic reviewP Daniel Patterson, Mary K Liszka, Quentin S Mcilvaine, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Circulation|October 15, 1996
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trialH D White, G I Barbash, R M Califf, et al.
Archives of Pathology & Laboratory Medicine|July 11, 2000
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999P L Fitzgibbons, D L Page, D Weaver, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 6, 2023
Associations between obstructive sleep apnea and COVID-19 infection and hospitalization among US adultsStuart F Quan, Matthew D Weaver, Mark É Czeisler, et al.
Molecular Pharmacology|May 2, 2009
A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learningDouglas J Sheffler, Richard Williams, Thomas M Bridges, et al.
Pageof 87